key: cord-0860295-ktp05d1w
authors: Enwemeka, Chukuka S.; Bumah, Violet V.; Castel, J. Chris; Suess, Samantha L.
title: Pulsed blue light, saliva and curcumin significantly inactivate human coronavirus
date: 2021-12-28
journal: J Photochem Photobiol B
DOI: 10.1016/j.jphotobiol.2021.112378
sha: b956d614c539f5a7a90c9e92f42ca4a30a135000
doc_id: 860295
cord_uid: ktp05d1w

In a recent study, we showed that pulsed blue light (PBL) inactivates as much as 52.3% of human beta coronavirus HCoV-OC43, a surrogate of SARS-CoV-2, and one of the major strains of viruses responsible for the annual epidemic of the common cold. Since curcumin and saliva are similarly antiviral and curcumin acts as blue light photosensitizer, we used Qubit fluorometry and WarmStart RT-LAMP assays to study the effect of combining 405 nm, 410 nm, 425 nm or 450 nm wavelengths of PBL with curcumin, saliva or a combination of curcumin and saliva against human beta coronavirus HCoV-OC43. The results showed that PBL, curcumin and saliva independently and collectively inactivate HCoV-OC43. Without saliva or curcumin supplementation 21.6 J/cm(2) PBL reduced HCoV-OC43 RNA concentration to a maximum of 32.8% (log(10) = 2.13). Saliva supplementation alone inactivated the virus, reducing its RNA concentration by 61% (log(10) = 2.23); with irradiation the reduction was as much as 79.1%. Curcumin supplementation alone decreased viral RNA 71.1%, and a maximum of 87.8% with irradiation. The combination of saliva and curcumin reduced viral RNA to 83.1% and decreased the RNA up to 90.2% with irradiation. The reduced levels could not be detected with qPCR. These findings show that PBL in the range of 405 nm to 450 nm wavelength is antiviral against human coronavirus HCoV-OC43, a surrogate of the COVID-19 virus. Further, it shows that with curcumin as a photosensitizer, it is possible to photodynamically inactivate the virus beyond qPCR detectable level using PBL. Since HCoV-OC43 is of the same beta coronavirus family as SARS-CoV-2, has the same genomic size, and is often used as its surrogate, these findings heighten the prospect of similarly inactivating novel coronavirus SARS-CoV-2, the virus responsible for COVID-19 pandemic.

With the recent outbreak of novel Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which has infected more than 244 million, killed nearly five million and caused untold socio-economic devastation worldwide [1], research to advance the development and deployment of an antiviral agent capable of inactivating coronaviruses in the environment and in patient care scenarios has been on the rise. This has caused a resurgence of Photodynamic Inactivation (PDI), i.e., the use of light to excite a chemical photosensitizer to engender downstream inactivation of microorganisms. The first evidence that PDI effectively inactivates viruses emerged as early as the 1930s when Perdrau and Todd [2] used a combination of visible light and methylene blue to inactivate herpes virus, vaccinia virus, two avian viruses, canine distemper virus, and a host of other viruses.

With improvements in light technology and the emergence of relatively inexpensive light emitting diodes (LEDs), interest in PDI has been on the rise. Since the 1970s combinations of various spectra of light and photosensitizers have been used to inactivate a multitude of pathogens, including viruses that cause HIV-AIDS, viruses, such as coronaviruses, are more susceptible to photo-damage than nonenveloped viruses [20] [21] [22] [23] [24] . The latter finding suggests that human coronaviruses, for example, HCoV-OC43, HCoV-229E and SARS-CoV-2, may be susceptible to PDI.

Studies have shown that even in the absence of a photosensitizer or an endogenous chromophore, certain wavelengths of light-besides ultraviolet light (UV)-can inactivate viruses. Violet-blue light inactivates baculoviruses [25] , leukemia virus [26] , feline calicivirus [27] , HIV [28] , herpes simplex [29] and the flu virus [30] . For example, murine leukemia virus exposed to blue 420 -430 nm light lost significant infectivity compared to control viruses that were kept in darkness [26] . The antiviral effect was not due to UV which was eliminated by light filtration, neither was it due to the presence of an endogenous or exogenous chromophore which-if at all present-was experimentally neutralized. The loss of infectivity was shown to be light-induced impairment of the reverse transcription process [26] . Support for this finding comes from a recent work which showed that two surrogates of SARS-CoV-2, human beta coronavirus HCoV-OC43 and human alpha coronavirus HCoV-229E, are susceptible to 405 nm, 410 nm, 425 nm and 450 nm pulsed blue light (PBL) in the absence of a photosensitizer [31] . Irradiation with 425 nm PBL alone, using ultralow 12 mW/cm 2 irradiance and a dose of 130 J/cm 2 inactivated as much as 2.37 log10 (52.3%) HCoV-OC43 and 1.46 log 10 (43.8%) HCoV-229E. Inactivation of both viruses was less at a lower irradiance and dose, suggesting J o u r n a l P r e -p r o o f Journal Pre-proof that, perhaps at higher doses or with other ways of improving the protocol, 100% inactivation of the viruses may be attained [31] .

Since certain photosensitizers potentiate the effect of light, it seems plausible that a combination of PBL and a blue light-absorbing photosensitizer will be more antiviral than light alone and may yield 100% inactivation of coronaviruses even at a relatively low irradiance and dose. Curcumin, the active ingredient in turmeric (Curcuma longa L) with a long history of being an antioxidant, anti-inflammatory, anti-cancer, and anti-diabetic [32] , is a known blue light-absorber with peak absorption at 425 nm [33, 34] , and can act as a photosensitizer. Like violet-blue light, it is antiviral against several viruses, including hepatitis virus [35] [36] [37] [38] [39] [49, 50] , norovirus [51] , as well as Zika virus [52, 53] , Dengue virus and chikungunya virus, [41, [53] [54] [55] , and human immunodeficiency virus (HIV) [56] [57] [58] [59] [60] . These findings suggest that curcumin could potentiate the antiviral effect of PBL.

In addition to curcumin, saliva supplementation was tested because of its 

Custom-made PBL equipment, obtained from Carewear Corp., Reno, Nevada, USA, was used for this study. The light sources used were conventional high efficiency LEDs which were mounted on plastic bridges and were calibrated to produce an average irradiance of 12 mW/cm 2 with a peak irradiance of 36 mW/cm 2 at the surface of the virus samples. The average irradiance produced by each light source was factory calibrated using a Labsphere ILLUMIA PLUS 610-050-2Pi integrating sphere and a spectrometer to an accuracy of +/-5%. Average irradiance values were measured at the surface of the viral samples with a calibrated Thorlabs PM100A -Compact power meter console. Each device emitted pulsed light either at 405 nm, 410nm, 425 nm or 450 nm wavelength depending on the user's choice. At each J o u r n a l P r e -p r o o f Journal Pre-proof wavelength, the spectral width was approximately 20 nm. The light was square wave pulsed at 33Khz with a 33% duty cycle-i.e., light emitted 33% of the time and off 67% of the time. The pulse duration was 10 microseconds with an off time of 20 microseconds. The irradiation parameters were selected based on prior studies [31] .

Water soluble Curcumin consisting of a mixture of N-Acetylcysteine -Curcumin complex and Tumeric Curcuminoids was obtained from Ultra Botanica LLC, Oklahoma City, Oklahoma, and was used for this study. Based on the recommendations and measured bioavailability in mouse models and human subjects provided by the manufacturer, we used a curcumin level of 10 micromolar in aqueous solution. We prepared the stock solution of curcumin by dissolving 14,720 g/L in sterile water. For each experiment, 70 µL of the stock solution was added to 140 µL of 5 x 10 3 PFU/mL virus. The curcumin supplementation experiment was intended to mimic the potential effect of PBL irradiation of the mouth following curcumin consumption.

The pharmaceutical grade artificial saliva (pH of 6.8) was obtained from saliva supplementation experiment was intended to mimic the potential effect of PBL in the oral cavity.

Viral titers of 5 x 10 3 PFU mL -1 of HCoV-OC43 coronavirus, obtained from the American Type Culture Collection (Beta coronavirus 1, ATCC® VR1558™), were used for the experiment. Aliquots of 140 µL of 5 x 10 3 PFU mL -1 of the virus were then transferred into different six well plates and supplemented with either 70 µL (10 µM) of curcumin, 70 µL of artificial saliva, or a combination of 70 µL curcumin and 70 µL artificial saliva. Plates were then irradiated with either 405 nm, 410 nm, 425 nm or 450 nm PBL, using 21.6 J/cm 2 fluence at 12mW/cm 2 irradiance. The control group was neither irradiated nor supplemented with a photosensitizer (Table 1) .

Each set of experiment was repeated three times; then viral RNA was extracted using a Qiagen RNA extraction kit, and quantitated using a Qubit fluorometer and RT-LAMP as detailed below. membrane. The spin columns were centrifuged at 6000 x g (8000 rpm) for 1 min and the filtrate discarded. The rest of the sample was then added to the column, centrifuged at the same speed for 1 min and the filtrate discarded. This process allowed the RNA to bind unto the membrane; contaminants were then washed away by adding 500 µL wash buffer 1 and centrifuging at 6000 x g (8000 rpm) for 1 min. A second 500 µL wash buffer (wash buffer 2) was then added to the column and centrifuged at full speed (20,000 x g, 14,000 rpm) for 3 min. The column was then placed in a clean DNase/RNase free 1.5 mL microcentrifuge tube and 40 µL of buffer AVE (RNase-free water containing 0.04% sodium azide, elution buffer) added and allowed to equilibrate at room temperature for 1 min before centrifuging at 6000 x g (8000 rpm) for 1 min. Another 40 µL of buffer AVE was added to the column and the elution process repeated. The high-quality RNA eluted, was quantitated immediately using the Qubit fluorometer or LAMP PCR; alternatively, it was stored at -20 o C for use later. Experiments were repeated four times with each wavelength.

The WarmStart RT-LAMP test is an ultrasensitive assay based on a one-step Loop-Mediated Isothermal Amplification (LAMP) of RNA targets. It has been used to detect HCoV-OC43 [31] as well as SARS-CoV-2 [72, 73] . The assay uses isothermal amplification techniques that provide rapid detection of a target nucleic acid, using LAMP-specific primers and a strand-displacing DNA polymerase. The kit (New England Biolabs) contains the WarmStart LAMP 2X master mix, which is a blend of 

At each of the four wavelengths, PBL irradiation without curcumin and/or saliva supplementation reduced HCoV-OC43 RNA concentration by 6.5% to 32.8% J o u r n a l P r e -p r o o f

As shown in Figure 4 and Table 2 , saliva supplementation alone, significantly reduced percent RNA concentration to 39% (log10 = 2.23; p< 0.001). This finding supports previous reports which show that saliva is antiviral [59] [60] [61] [62] [63] [64] [65] . Further, at each wavelength tested, the combination of saliva and PBL was more Table 2 ), indicating that these wavelengths more effectively potentiate the photosensitizing effects of curcumin. 

Our findings confirm that PBL alone is antiviral against human coronavirus HCoV-OC43, and that saliva and curcumin independently and jointly inactivate i.e., the viral core [26] , particularly when used with a photosensitizer such as curcumin [76] . The antimicrobial effect of saliva seems related to its biochemical composition. Purified salivary proteins, such as histatins, human neutrophil defensins, MUC5B, and the scavenger receptor cysteine-rich glycoprotein 340 (GP340) have been shown to inhibit influenza virus A; GP340 also inhibits HIV [77] .

Other components of saliva known to be antiviral include cathelcidin (LL-37), lactoferrin, lysozyme, mucins, peroxidase, salivary agglutinin (gp340, DMBT1), sIgA, SLPI, and α and β defensins [77] . These findings suggest that any or a combination of these biochemical components of saliva could be responsible for the observed antiviral effect of saliva against HCoV-OC43.

Curcumin has been shown to be antiviral against several viruses, including hepatitis virus [35,37- These reports suggest that, like PBL and saliva, curcumin targets and fragments viral nucleic acids.

The results obtained from the two assays, Qubit Fluorometry and WarmStart The WarmStart RT-LAMP results clearly showed that irradiation with PBL using curcumin or combined curcumin and saliva as supplements inactivates HCoV-OC43

to levels that are beyond detection, indicating that either there was no intact viral RNA whatsoever or that whatever was left was so minimal that it could not be detected by WarmStart RT-LAMP-the gold standard assay used to determine the presence or absence of coronavirus infection clinically.

Photodynamic inactivation using combined saliva and curcumin was slightly more effective than irradiation of samples supplemented with curcumin alone; however, the difference was not statistically significant (p > .05). The combined effect of both supplements was not cumulative but synergistic. This finding suggests a common mechanism of action of PBL and both supplements. and 450 nm wavelengths [31] . Therefore, our finding that at a lower fluence, 21.7 J/cm 2 , 405 nm PBL was less effective in clearing the virus than 425 nm or 450 nm may be due to the significantly lower irradiation dose used in the present study.

Moreover, more virus was inactivated at the higher doses used in the previous study, and this supports the view that PBL is more antiviral at higher doses than lower doses [31] .

With saliva and/or curcumin supplementation, the two longer wavelengths, 425 nm and 450 nm, also were consistently more effective in inactivating the virus than the two shorter wavelengths, 405 nm or 410 nm. This finding is consistent with the fact that as a photosensitizer, curcumin absorbs blue light mostly in the longer wavelength ranges used in this study. These same wavelengths potentiate the antiviral effect of curcumin more so than the shorter wavelengths, and this relates to the absorption spectra of curcumin with peak absorption in the range of 420 nm to 440 nm [33, 34, 80] . Blue light is innocuous and safe when used at appropriate doses. It has been used by dentists for surgery and to cure resins for decades without adverse effects.

Further, PBL has been shown to eradicate bacteria [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] 

The photodynamic action of methylene blue on certain viruses

Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively

Photoinactivation of hepatitis A virus by synthetic porphyrins

Hepatitis C and human immunodeficiency virus RNA degradation by methylene blue/light treatment of human plasma

Mitochondrial DNA multiplex real-time polymerase chain reaction inhibition assay for quality control of pathogen inactivation by ultraviolet C light in platelet concentrates

Methylene blue treated freshfrozen plasma: what is its contribution to blood safety

Photodynamic virus inactivation of blood components

Updates on pathogen inactivation of plasma using Theraflex methylene blue system

Virus inactivation in blood components by photoactive Phenothiazine dyes

Evaluation of resistance development and viability recovery by a non-enveloped virus after repeated cycles of aPDT

Wavelength dependence of oxidative DNA 23

New phthalocynanines for photodynamic virus inactivation in red blood cell concentrates

Photodynamic inactivation of enveloped viruses by buckminsterfullerene

Long-term stability of baculoviruses stored under various conditions

Inactivation of murine leukaemia virus by exposure to visible light

New proof-of-concept in viral inactivation: Virucidal efficacy of 405 nm light against feline calicivirus as a model for norovirus decontamination

Target structures for HIV-1 inactivation by methylene blue and light

The influence of simulated sunlight on the inactivation of influenza virus in aerosols

Pulsed blue light inactivates two strains of human coronavirus

Anti-infective properties of the golden spice curcumin

Fabrication and vibration characterization of curcumin extracted from turmeric (Curcuma longa) rhizomes of the northern Vietnam

Optimization and validation of high-performance liquid chromatography method for individual curcuminoids in turmeric by heat-refluxed extraction

Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. J. study. Asian Pac

Mechanism of curcumin resistance to human cytomegalovirus in HELF cells

Curcumin inhibits human cytomegalovirus by downregulating heat shock protein 90

Curcumin shows antiviral properties against norovirus

Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro

Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding

Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system

Inhibitory effects of curcumin on dengue virus type 2-infected cells in vitro

Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes

Inhibition of human immunodeficiency virus type-1 integrase by curcumin

Active site binding modes of curcumin in HIV-1 protease and integrase

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription

Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat

The mouth: A gateway or a trap for HIV?

Multiple components contribute to ability of saliva to inhibit influenza viruses

Salivary Blockade Protects the Lower Respiratory Tract of Mice from Lethal Influenza Virus Infection

Antiviral activities in human saliva

The impact of oral health on respiratory viral infection

Antiviral activities in human saliva

Common Colds: Protect Yourself 70

Coronaviruses: an overview of their replication and pathogenesis

Coronavirus genomics and bioinformatics analysis

) 73. World Health Organization: Middle East respiratory syndrome coronavirus

Host, viral, and environmental transcriptome profiles of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). (2020) bioRxiv preprint doi

Rapid and simple method for purification of nucleic acids

Virucidal efficacy of treatment with photodynamically activated curcumin on murine norovirus bio-accumulated in oysters

Antiviral activities in human saliva

Chemopreventive effect of Curcuma longa Linn on liver pathology in HBx transgenic mice

Structure-activity relationship analysis of curcumin analogues on antiinfluenza virus activity

Studies on complex formation between curcumin and Hg (II) ion by spectrophotometric method: A new approach to overcome peak overlap

SARS-CoV-2 viral load in upper respiratory specimens of infected patients

Innate antimicrobial activity of nasal secretions

Optimizing the bactericidal effect of pulsed blue light on Propionibacterium acnes -a correlative fluorescence spectroscopy study

nm SLD Photo-destroys methicillin resistant staphylococcus aureus (MRSA) in vitro

470 nm blue light kills methicillin resistant staphylococcus aureus (MRSA) in vitro

Pulsed 450 nm blue light significantly inactivates Propionibacterium acnes more than continuous wave blue light

Phototoxic effect of visible light on Escherichia coli, Pseudomonas aeruginosa

Blue 470 nm light suppresses the growth of Salmonella enterica and methicillin-resistant Staphylococcus aureus (MRSA) in vitro

Enhanced inactivation of Escherichia coli and Listeria monocytogenes by exposure to 405 nm light under sub-lethal temperature, salt and acid stress conditions

Blue light kills Aggregatibacter actinomycetemcomitans due to its endogenous photosensitizers